Market Closed -
OTC Markets
09:37:22 2024-05-28 EDT
|
5-day change
|
1st Jan Change
|
0.000001
USD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Capitalization
1 |
94.13
|
97.95
|
34.35
|
16.83
|
25.53
|
10.06
|
Enterprise Value (EV)
1 |
94.19
|
94.92
|
34.87
|
23.16
|
30.83
|
23.37
|
P/E ratio
|
-15.5
x
|
-5.8
x
|
-0.66
x
|
-0.25
x
|
-0.45
x
|
-1.08
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
255,152,211
x
|
220,547,389
x
|
526,083,200
x
|
11,255,186
x
|
3,193,102
x
|
EV / Revenue
|
-
|
247,262,122
x
|
223,875,644
x
|
723,739,450
x
|
13,592,488
x
|
7,417,546
x
|
EV / EBITDA
|
-43.5
x
|
-28
x
|
-2.27
x
|
-1.13
x
|
-7.68
x
|
-5.64
x
|
EV / FCF
|
-444
x
|
-51
x
|
-3.79
x
|
-1.34
x
|
3.63
x
|
-18.8
x
|
FCF Yield
|
-0.23%
|
-1.96%
|
-26.4%
|
-74.5%
|
27.5%
|
-5.32%
|
Price to Book
|
173
x
|
7.68
x
|
0.88
x
|
0.26
x
|
1.14
x
|
-29.5
x
|
Nbr of stocks (in thousands)
|
16,850
|
23,459
|
58,201
|
108,113
|
133,146
|
159,929
|
Reference price
2 |
5.586
|
4.176
|
0.5902
|
0.1557
|
0.1917
|
0.0629
|
Announcement Date
|
16-08-02
|
17-07-31
|
18-07-30
|
19-07-26
|
20-09-11
|
22-05-02
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net sales
|
-
|
0.3839
|
0.1557
|
0.032
|
2.268
|
3.15
|
EBITDA
1 |
-2.165
|
-3.393
|
-15.35
|
-20.58
|
-4.013
|
-4.144
|
EBIT
1 |
-2.168
|
-3.61
|
-15.64
|
-21.31
|
-9.642
|
-5.731
|
Operating Margin
|
-
|
-940.27%
|
-10,038.66%
|
-66,603.12%
|
-425.13%
|
-181.94%
|
Earnings before Tax (EBT)
1 |
-3.295
|
-9.988
|
-20.59
|
-28.18
|
-37.44
|
-8.179
|
Net income
1 |
-3.295
|
-9.988
|
-20.59
|
-28.18
|
-39.96
|
-8.848
|
Net margin
|
-
|
-2,601.63%
|
-13,222.19%
|
-88,056.25%
|
-1,761.86%
|
-280.89%
|
EPS
2 |
-0.3601
|
-0.7203
|
-0.8886
|
-0.6190
|
-0.4253
|
-0.0581
|
Free Cash Flow
1 |
-0.212
|
-1.86
|
-9.211
|
-17.25
|
8.488
|
-1.244
|
FCF margin
|
-
|
-484.55%
|
-5,914.08%
|
-53,919.53%
|
374.23%
|
-39.48%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16-08-02
|
17-07-31
|
18-07-30
|
19-07-26
|
20-09-11
|
22-05-02
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
0.06
|
-
|
0.52
|
6.33
|
5.3
|
13.3
|
Net Cash position
1 |
-
|
3.03
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.0295
x
|
-
|
-0.0338
x
|
-0.3074
x
|
-1.321
x
|
-3.211
x
|
Free Cash Flow
1 |
-0.21
|
-1.86
|
-9.21
|
-17.3
|
8.49
|
-1.24
|
ROE (net income / shareholders' equity)
|
-471%
|
-182%
|
-140%
|
-96.9%
|
-141%
|
-614%
|
ROA (Net income/ Total Assets)
|
-115%
|
-32.7%
|
-55.7%
|
-36.2%
|
-14.2%
|
-17.7%
|
Assets
1 |
2.873
|
30.55
|
36.94
|
77.91
|
280.8
|
49.9
|
Book Value Per Share
2 |
0.0300
|
0.5400
|
0.6700
|
0.5900
|
0.1700
|
-0
|
Cash Flow per Share
2 |
0.0300
|
0.2200
|
0.0300
|
0
|
0
|
0
|
Capex
1 |
0.88
|
1.94
|
7.65
|
11.5
|
0.86
|
0.47
|
Capex / Sales
|
-
|
506.28%
|
4,911.57%
|
35,993.75%
|
38.01%
|
15.05%
|
Announcement Date
|
16-08-02
|
17-07-31
|
18-07-30
|
19-07-26
|
20-09-11
|
22-05-02
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 197 | | -.--% | 339M | | +23.05% | 242M | | +4.12% | 215M | | +33.14% | 173M | | +122.41% | 129M | | -28.57% | 121M | | +28.91% | 117M | | -52.87% | 97.14M | | 0.00% | 86.95M |
Medical Farming
|